Literature DB >> 6335421

The detection of circulating immune complexes containing C1q and IgG using a new rapid serum ELISA test system.

R P Reckel, J Harris, E Botsko, R Wellerson, S Varga.   

Abstract

An ELISA sandwich assay for detecting circulating immune complexes (CIC) was evaluated. Heat-aggregated IgG (HAG) containing Clq (HAG:Clq) is used to generate standard curves for quantitation of CIC. Sera from 488 normal donors had an means of 3.8 +/- 15.3 micrograms/ml HAG eq and 97.1% had concentrations less than 35 micrograms/ml HAG eq (2 SD greater than means) and were considered negative. Sera from rheumatoid arthritis (RA) patients in active disease tested 86% positive for CIC (means = 104.5 +/- 63.4 micrograms/ml HAG eq) while 100% with inactive disease were negative (means = 11.4 +/- 3.7 micrograms/ml HAG eq). Similarly, in systemic lupus erythematosus (SLE) patients with active disease, 100% were positive (means = 133.1 +/- 50.6 micrograms/ml HAG eq) while 80% with inactive disease were negative (means = 20.4 +/- 21.4 micrograms/ml HAG eq). In AIDS (AIDS related), 88.5% of AIDS sera and 77.1% of lymphadenopathy syndrome (LAS) sera had elevated CIC. Sera from asymptomatic homosexual controls showed 85% positive for CIC. The serum ELISA test for CIC compared favorably with the 125I-staphylococcus binding assay but was more sensitive than the 125I-C1qBA. The OKT4/OKT8 ratios were also significantly reduced in AIDS and LAS.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6335421

Source DB:  PubMed          Journal:  Diagn Immunol        ISSN: 0735-3111


  2 in total

1.  Evaluation of anti-C1q capture assay for detecting circulating immune complexes and comparison with polyethylene glycol-immunoglobulin G, C1q-binding, and Raji cell methods.

Authors:  S S Levinson; J O Goldman
Journal:  J Clin Microbiol       Date:  1987-08       Impact factor: 5.948

2.  C1q-bearing immune complexes detected by a monoclonal antibody to human C1q in rheumatoid arthritis sera and synovial fluids.

Authors:  U Antes; H P Heinz; D Schultz; D Brackertz; M Loos
Journal:  Rheumatol Int       Date:  1991       Impact factor: 2.631

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.